It seems we can’t find what you’re looking for. Perhaps searching can help.
1933 - 2022
Odette Cancer Centre – An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation